Rexulti and Chantix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rexulti (brexpiprazole) and Chantix (varenicline tartrate). Common drug interactions include hiatus hernia among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Rexulti and Chantix. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Rexulti?

Rexulti has active ingredients of brexpiprazole. It is often used in major depression. eHealthMe is studying from 13,394 Rexulti users. Check the latest studies of Rexulti.

What is Chantix?

Chantix has active ingredients of varenicline tartrate. It is often used in quit smoking. eHealthMe is studying from 89,889 Chantix users. Check the latest studies of Chantix.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Jul, 03, 2026

28 people who take Rexulti and Chantix together, and have interactions are studied.

Rexulti and Chantix drug interactions.

What are the common drug interactions of Rexulti and Chantix, by gender? *:

female:

  1. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  4. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  5. Haematuria (presence of blood in urine)
  6. Acute respiratory distress syndrome
  7. Acute respiratory failure
  8. Disturbance in attention
  9. Embolic stroke (stroke due to obstruction due to an embolus)
  10. Nightmare (unpleasant dream)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Foot fracture
  4. Vertigo
  5. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
  6. Antisocial behaviour
  7. Depression
  8. Chronic kidney disease
  9. Emotional distress
  10. Osteoporosis (bones weak and more likely to break)

What are the common drug interactions of Rexulti and Chantix, by age (0-1 to 60+)? *:

0-1:

  1. Death

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
  3. Abdominal distension
  4. Bell's palsy (facial paralysis)
  5. Death
  6. Drug ineffective
  7. Genital herpes (herpes infection of genital)
  8. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  9. Hypertension (high blood pressure)
  10. Intestinal obstruction

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Osteoporosis (bones weak and more likely to break)
  6. Pain
  7. Renal tubular necrosis (death of kidney tubules)
  8. Bone density decreased
  9. Renal failure (kidney dysfunction)
  10. Disturbance in attention

60+:

  1. Acute respiratory distress syndrome
  2. Acute respiratory failure
  3. Weight decreased
  4. Embolic stroke (stroke due to obstruction due to an embolus)
  5. Pneumonia escherichia (pneumonia due to bacteria escherichia coli)
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Septic shock (shock due to blood infection)
  8. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  9. Tricuspid valve incompetence (inefficient heart valve)
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 39.29%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 21.43%
  3. Hiv Infection: 4 people, 14.29%
  4. Prostate Cancer: 2 people, 7.14%
  5. Depression: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Rexulti and Chantix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rexulti and Chantix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rexulti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Chantix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rexulti and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Chantix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on brexpiprazole and varenicline tartrate (the active ingredients of Rexulti and Chantix, respectively), and Rexulti and Chantix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: